Guohua Yu

2.5k total citations · 1 hit paper
76 papers, 1.1k citations indexed

About

Guohua Yu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guohua Yu has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guohua Yu's work include Lung Cancer Treatments and Mutations (8 papers), Natural product bioactivities and synthesis (6 papers) and Transcranial Magnetic Stimulation Studies (6 papers). Guohua Yu is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Natural product bioactivities and synthesis (6 papers) and Transcranial Magnetic Stimulation Studies (6 papers). Guohua Yu collaborates with scholars based in China, United States and Sweden. Guohua Yu's co-authors include Zhiqiang Luo, Yuanyuan Shi, Yating Zhou, Lei Ding, Xu Wang, Lili Zhang, Meng Xu, Rui Guo, Yuanyuan Shi and Jianming Ying and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Endocrine Reviews.

In The Last Decade

Guohua Yu

66 papers receiving 1.1k citations

Hit Papers

Open-label, Multicenter, Phase II Study of RC48-ADC, a HE... 2020 2026 2022 2024 2020 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
    2020 192 citations Xinan Sheng, Xieqiao Yan et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guohua Yu China 18 367 238 215 146 132 76 1.1k
Sheng Liu China 18 678 1.8× 106 0.4× 315 1.5× 96 0.7× 151 1.1× 119 1.8k
Yuyu Liu China 19 634 1.7× 123 0.5× 95 0.4× 104 0.7× 130 1.0× 72 1.2k
Yuan Du China 24 781 2.1× 100 0.4× 171 0.8× 134 0.9× 70 0.5× 68 1.5k
Hui Cai China 26 954 2.6× 181 0.8× 166 0.8× 219 1.5× 108 0.8× 78 1.8k
Xiaoqiang Yue China 18 427 1.2× 179 0.8× 118 0.5× 73 0.5× 117 0.9× 39 1.1k
Yu Huang China 19 452 1.2× 89 0.4× 153 0.7× 68 0.5× 84 0.6× 72 1.2k
Zheng Yang China 28 814 2.2× 144 0.6× 128 0.6× 80 0.5× 88 0.7× 51 1.7k
Qinghua Lu China 26 988 2.7× 282 1.2× 180 0.8× 147 1.0× 122 0.9× 70 1.9k

Countries citing papers authored by Guohua Yu

Since Specialization
Citations

This map shows the geographic impact of Guohua Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohua Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohua Yu more than expected).

Fields of papers citing papers by Guohua Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guohua Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohua Yu. The network helps show where Guohua Yu may publish in the future.

Co-authorship network of co-authors of Guohua Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Guohua Yu. A scholar is included among the top collaborators of Guohua Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guohua Yu. Guohua Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Xiuying, Yaru Feng, Jingjing Liu, et al.. (2025). Novel and effective tandem CD38 and CD19 targeting CAR-T cells inhibit hematological tumor immune escape. Cellular Immunology. 411-412. 104950–104950.
3.
Zheng, Jing, Yue Cui, Xinyu Wang, et al.. (2025). The Role of Artesunate in Cancer Management: Mechanisms of Biomedical Effects and Toxicology. The American Journal of Chinese Medicine. 53(8). 2489–2512.
4.
5.
Luo, Zhiqiang, Runming Jin, Rong Guo, et al.. (2025). Integration analysis of miRNA-mRNA uncovers the mechanisms of ochratoxin A-induced hepatotoxicity. Ecotoxicology and Environmental Safety. 293. 118039–118039. 2 indexed citations
6.
Wang, Jie, Zhehai Wang, Yao Yu, et al.. (2024). Efficacy and safety of MCLA-129, an EGFR/c-MET bispecific antibody, in advanced non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 42(16_suppl). 8604–8604. 5 indexed citations
7.
Li, Shilin, et al.. (2024). Dysphagia in Parkinson's disease: A bibliometric and visualization analysis from 2002 to 2022. Heliyon. 10(9). e30191–e30191. 1 indexed citations
8.
Zhang, Qingyun, et al.. (2024). Thyroid Metastases from Triple-Negative Breast Cancer with High PD-L1 Expression – A Rare Presentation. OncoTargets and Therapy. Volume 17. 103–107.
9.
Yu, Guohua, et al.. (2024). Modeling the Impact of Wind Drag Coefficient on Wind-Driven Currents in Lake Taihu, China. Water. 16(20). 2985–2985. 1 indexed citations
10.
11.
12.
Wu, Jingliang, Xueying Ding, Mengmeng Sun, et al.. (2022). Dual-Ligand-Modified Nanoscale Liposomes Loaded with Curcumin and Metformin Inhibit Drug Resistance and Metastasis of Hepatocellular Carcinoma. ACS Applied Nano Materials. 5(5). 7063–7077. 4 indexed citations
13.
Wang, Juan, Shun Lü, Yehuan Sun, et al.. (2021). OA03.04 Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(1). S3–S3. 1 indexed citations
14.
15.
Sheng, Xinan, Xieqiao Yan, Lin Wang, et al.. (2020). Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma. Clinical Cancer Research. 27(1). 43–51. 192 indexed citations breakdown →
16.
17.
Luo, Zhiqiang, Guohua Yu, Xing Han, et al.. (2019). Prediction of the pharmacokinetics and pharmacodynamics of topiroxostat in humans by integrating the physiologically based pharmacokinetic model with the drug-target residence time model. Biomedicine & Pharmacotherapy. 121. 109660–109660. 18 indexed citations
18.
Luo, Zhiqiang, et al.. (2017). Development of a validated HPLC method for the quantitative determination of trelagliptin succinate and its related substances in pharmaceutical dosage forms. European Journal of Pharmaceutical Sciences. 111. 458–464. 8 indexed citations
19.
Yu, Guohua. (2007). Effect of tea saponin on blood pressure in spontaneously hypertensive rats. 2 indexed citations
20.
Yu, Guohua. (2006). Clinical study on endoscopic therapy of esophageal variceal bleeding. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheng Liu Breakdown of academic impact, for papers by Yuyu Liu Breakdown of academic impact, for papers by Yuan Du Breakdown of academic impact, for papers by Hui Cai Breakdown of academic impact, for papers by Xiaoqiang Yue Breakdown of academic impact, for papers by Yu Huang Breakdown of academic impact, for papers by Zheng Yang Breakdown of academic impact, for papers by Qinghua Lu
Rankless by CCL
2026